FIRST-ENGOT-OV44 phase III trial

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

FIRST-ENGOT-OV44 phase III trial

Dec 22, 2024, 16:56 | Insight

GSK Announced Landmark Results from FIRST Trial in First-Line Advanced Ovarian Cancer

GSK has announced that the FIRST-ENGOT-OV44 phase III trial evaluating the combination of Zejula (niraparib)…

All: 1 Posts: 1 - 100

'

New Paper Alert: HARMONi-2 study of Ivonescimab vs pembrolizumab for PD-L1-positive non-small cell lung cancer

'

We are thrilled to welcome Dr. Jasmine Kamboj to the OncoDaily Editorial Board!

'

Oncologist Near Me – Fedro Alessandro Peccatori: Leading Expert in Gynecological Oncology

'

MATTERHORN trial - FLOT plus durvalumab will become the new standard of care in the preoperative setting for gastroesophageal cancer

'

Daiichi Sankyo's and Astrazeneca's press release on ENHERTU®: Latest Updates from DESTINY-Gastric04 trial

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023